Asante Capital congratulates its partner BPOC on establishing a $425 million continuation fund

The fund is co-led by Apollo S3, Blackstone Strategic Partners and Five Arrows

We are delighted to announce that BPOC, a pure-play healthcare investor, announced the closing of its first continuation vehicle, a $425 million transaction co-led by investment funds affiliated with Apollo S3, Blackstone Strategic Partners and Five Arrows.

The continuation fund consists of five healthcare services companies previously held by Beecken Petty O’Keefe & Company Fund IV, L.P. and Beecken Petty O’Keefe & Company Fund IV-A, L.P. (together “BPOC Fund IV”), 2013 vintage funds with $503 million in combined total capital commitments.

The continuation fund will provide more time and, in certain cases, additional capital to assist each portfolio company in further accelerating its full growth potential. Existing investors in BPOC Fund IV were provided with the choice to receive full liquidity or to fully or partially re-invest into the new continuation fund.

“We are grateful for the support of our new investors and believe this new vehicle will enable us to continue to create value at certain Fund IV companies, while providing liquidity options for our existing Fund IV investors,” said Gregory Moerschel, Managing Partner of BPOC.

Asante Capital Group Advisors LLC acted as exclusive advisor to BPOC on the transaction. Kirkland & Ellis LLP and Paul Hastings LLP served as legal counsel to BPOC, while Proskauer Rose LLP represented Apollo S3, Blackstone Strategic Partners and Five Arrows.

About BPOC 

BPOC is a Chicago-based private equity firm that invests exclusively in healthcare companies. With an extensive network of industry contacts and dedicated operating executives, BPOC has a track record of successfully partnering with companies through multiple economic and healthcare regulatory cycles.

Founded in 1996, BPOC has completed over 60 platform investments and has raised six funds with over $2.2 billion in total capital commitments. BPOC has invested in numerous providers, manufacturing, outsourcing, distribution and information technology companies through growth equity, management buyouts and leveraged recapitalizations. For more information, visit www.bpoc.com

To read more, click here.

Asante Capital congratulates partner HighLight Capital (HLC) on the final closing of its flagship HLC USD Fund IV at US$550 million

We are delighted to share that HighLight Capital (HLC), a private equity firm focusing on venture and growth investments across healthcare and consumer health sectors in China, held the final close of its flagship HLC USD Fund IV at US$550 million.

Asante Capital Group Celebrates 2023 Achievements, Extends Track Record of Successful Fundraises and Grows Global Team

As we enter 2024, Asante is pleased to announce another exceptional year, extending our track record of successful fundraising, strengthening our global presence and offerings, and facilitating expert discussions throughout 2023.

Asante Capital congratulates partner Abingworth on the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million

We are delighted to share that Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million.